In addition, CLDN18.2 expression status was not associated with OS or DFS in patients with GC who received surgery plus adjuvant chemotherapy, surgery plus palliative chemotherapy, or surgery only (Supplementary Figure S2). Here, CLDN18 is linked to gastric cancer.